SEC Form 3 · accession 0002144320-26-000002
BlossomHill Therapeutics, Inc. · BLSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Raymond Oxnard
Officer — Chief Medical Officer
Period of report
Aug 6, 2026
Accepted (ET)
Aug 6, 2026 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001839970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 17,785 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $5.63 | holding | — | — | — | — | Jan 2, 2035 | Common Stock | 152,373 | — | D |
| Employee Stock Option (Right to Buy)F1 | $6.28 | holding | — | — | — | — | Aug 21, 2035 | Common Stock | 34,031 | — | D |
Explanation of responses
- F1Immediately Exercisable.